Ron Bruehlman
Executive Vice President and Chief Financial Officer at IQVIA
GoodRx•Ridgefield, Connecticut, United States
View LinkedIn ProfileExecutive Overview
Senior financial executive with extensive leadership experience in multiple industries and with both public and private companies. Currently EVP and interim CFO of IQVIA, an S&P500 company and leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. Board member and chairman of audit committee of Atotech Ltd., a private equity owned global leader in surface finish solutions. Served for 5+ years as SVP and CFO of IMS Health, a $3.2B provider of information, services, and technology to the global healthcare industry. Previously served in various senior roles with United Technologies, a $60B global provider of high technology products and services to the building and aerospace industries. Expertise in general financial management, financial planning/analysis, investor relations, mergers and acquisitions, corporate strategy, treasury, capital markets, and manufacturing and service operations. Experience includes: Private/public company CFO experience (led IMS IPO in 2014) and currently EVP and Interim CFO of IQVIA. Executed $25B merger of equals with Quintiles Transnational in 2016 CFO of $15B global manufacturing division of public company. Substantial international experience, including Paris-based EMEA region CFO role Extensive interaction with security analyst and banking communities through - CFO of IMS Health - leadership of UTC investor relations - leadership of UTC global strategy and development - capital markets management in UTC Treasury Strong FP&A and operations finance background in manufacturing and service businesses at both the divisional and corporate levels Board member and Audit Committee chairman for publicly traded company in which UTC owned a non-controlling interest. Chairman of Board of Q-Squared Solutions, a joint venture between IQVIA Inc. and Quest Diagnostics, the second largest global provider of laboratory services for clinical trials. Specialties: General financial management Financial planning and analysis Investor relations Mergers and acquisitions Strategy Capital markets Treasury International business Manufacturing and service operations finance
Career Timeline
- GoodRxCurrentNov 2024–Present· 1 yr 11 mos
- Board Director and Audit Committee ChairCurrentNov 2024–Present
- IQVIACurrentOct 2016–Present· 10 yrs
- Executive Vice President, Chief Financial OfficerCurrentJul 2020–Present
- Senior Advisor to CEOOct 2016–Jul 2020
- Mar 2020–Aug 2022· 2 yrs 5 mos
- Board Director and Audit Committee ChairMar 2020–Aug 2022
- Jul 2011–Oct 2016· 5 yrs 3 mos
- Senior VP and Chief Financial OfficerJul 2011–Oct 2016
- May 2008–Apr 2011· 2 yrs 11 mos
- Vice President, Business DevelopmentJun 2009–Apr 2011
- VP, Operations Planning & Analysis, Commercial CompaniesMay 2008–Jun 2009
- Jun 2005–May 2008· 2 yrs 11 mos
- VP and Chief Financial OfficerJun 2005–May 2008
- Apr 2004–Jun 2005· 1 yr 2 mos
- VP, Financial Planning & AnalysisApr 2004–Jun 2005
- Oct 2000–Apr 2004· 3 yrs 6 mos
- Director, Financial Planning & AnalysisOct 2000–Apr 2004
- Apr 1999–Oct 2000· 1 yr 6 mos
- VP and CFO, Europe, Middle East, and AfricaApr 1999–Oct 2000
- Jun 1996–Apr 1999· 2 yrs 10 mos
- Director, Investor RelationsJun 1996–Apr 1999
Education
MBA
Finance
University of ChicagoBS
Economics
Alfred Lerner College of Business & Economics at University of Delaware